MD Anderson Receives Nearly $23 Million in CPRIT Funding for Cancer Research, Faculty Recruitment
Durvalumab Plus Chemo May be Promising Neoadjuvant Option in UTUC
Identifying and Addressing the Overlooked Need of Patient Sexual Health
Radioligand Therapies and Emerging Targets Drive Innovation in Prostate Cancer Management